Human cohort studies consistently show that offspring exposed to intrauterine hyperglycemia (from GDM, T2D, or type 1 diabetes) are at increased risk of obesity, insulin resistance, impaired insulin secretion, T2D, and cardiovascular dysfunction compared to children from the background population. This evidence concerns the gene INS and type 2 diabetes mellitus.